We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+4.27%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$203B
AUM Growth
+$19.6B
Cap. Flow
+$8.95B
Cap. Flow %
4.4%
Top 10 Hldgs %
24.49%
Holding
9,765
New
1,572
Increased
4,160
Reduced
2,819
Closed
1,012

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$702M
2
AMAT icon
Applied Materials
AMAT
+$507M
3
KDP icon
Keurig Dr Pepper
KDP
+$387M
4
KEY icon
KeyCorp
KEY
+$383M
5
V icon
Visa
V
+$349M

Sector Composition

Rank Sector Weight
1 Financials 6.16%
2 Technology 4.5%
3 Industrials 4.26%
4 Consumer Discretionary 4.07%
5 Healthcare 3.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHII
7801
DELISTED
Global X MSCI China Industrials ETF
CHII
$182K ﹤0.01%
13,042
-7,419
-36% -$110K
DSX icon
7802
PUT
Diana Shipping
DSX
$302M
$181K ﹤0.01%
53,923
-7,867
-13% -$22.8K
NYMX
7803
DELISTED
Nymox Pharmaceutical Corp
NYMX
$181K ﹤0.01%
53,725
+43,604
+431% +$168K
SCIN
7804
DELISTED
Columbia India Small Cap ETF
SCIN
$181K ﹤0.01%
10,676
-31,184
-74% -$605K
WT icon
7805
WisdomTree
WT
$2.96B
$180K ﹤0.01%
19,782
-1,544,016
-99% -$16.1M
VG
7806
CALL
DELISTED
Vonage Holdings Corporation
VG
$180K ﹤0.01%
+14,000
New +$161K
CMRE icon
7807
CALL
Costamare
CMRE
$1.88B
$179K ﹤0.01%
+22,400
New +$163K
RRD
7808
PUT
DELISTED
RR Donnelley & Sons Co.
RRD
$179K ﹤0.01%
31,000
+4,500
+17% +$33.2K
TTPH
7809
PUT
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$179K ﹤0.01%
2,505
+1,660
+196% +$117K
ADAP
7810
CALL
DELISTED
Adaptimmune Therapeutics
ADAP
$178K ﹤0.01%
15,000
+4,300
+40% +$53.6K
ARCO icon
7811
Arcos Dorados Holdings
ARCO
$1.72B
$178K ﹤0.01%
26,277
+8,516
+48% +$67.2K
CIA icon
7812
CALL
Citizens
CIA
$239M
$178K ﹤0.01%
22,800
+5,400
+31% +$41.6K
FCEL icon
7813
PUT
FuelCell Energy
FCEL
$1.73B
$178K ﹤0.01%
374
+261
+231% +$171K
NBRV
7814
CALL
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$178K ﹤0.01%
+205
New +$235K
JAG
7815
DELISTED
Jagged Peak Energy Inc.
JAG
$178K ﹤0.01%
13,705
-1,335,430
-99% -$17.5M
AAC
7816
PUT
DELISTED
AAC Holdings
AAC
$178K ﹤0.01%
+19,000
New +$208K
DNOW icon
7817
CALL
DNOW Inc
DNOW
$2.58B
$177K ﹤0.01%
+13,300
New +$175K
VSLR
7818
DELISTED
VIVINT SOLAR, INC.
VSLR
$177K ﹤0.01%
+35,697
New +$150K
AVEO
7819
PUT
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$176K ﹤0.01%
7,770
+5,600
+258% +$133K
HOS
7820
PUT
DELISTED
Hornbeck Offshore Services, Inc.
HOS
$176K ﹤0.01%
44,500
+3,500
+9% +$11.8K
NETI
7821
PUT
DELISTED
Eneti Inc.
NETI
$175K ﹤0.01%
2,647
+1,194
+82% +$82.2K
BLCM
7822
PUT
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$175K ﹤0.01%
2,370
-40
-2% -$3.12K
CSTM icon
7823
PUT
Constellium
CSTM
$3.76B
$174K ﹤0.01%
16,900
+5,500
+48% +$63.9K
IMUX icon
7824
CALL
Immunic
IMUX
$190M
$174K ﹤0.01%
+64
New +$148K
VCEL icon
7825
PUT
Vericel Corp
VCEL
$2.35B
$174K ﹤0.01%
17,900
+4,400
+33% +$54.8K

Similar funds

Citadel Advisors's Q2 2018 Portfolio in Review

As of Q2 2018, Citadel Advisors held 9,765 positions worth $203B, up 11% from $184B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Citadel Advisors deployed $8.95B of net new capital in Q2 2018, opening 1,572 new positions and adding to 4,160 existing holdings. Its largest new stake was Equitable Holdings: 16,008,962 shares worth $330M.

By sector, the portfolio is most concentrated in Financials at 6.2% of assets, up from 4.9% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $948M trimmed.

  • Citadel Advisors's largest Q2 2018 buy was Equitable Holdings: 16,008,962 shares worth $330M.
  • Citadel Advisors added most to Citigroup in Q2 2018, an estimated $702M increase.
  • Citadel Advisors's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $948M.
  • Citadel Advisors fully exited Time Warner Inc in Q2 2018, selling an estimated $268M.
  • Citadel Advisors's ten largest holdings make up 24% of its $203B portfolio in Q2 2018.
  • Citadel Advisors opened 1,572 new positions and closed 1,012 in Q2 2018.
  • Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $203B.

Based on Citadel Advisors's 13F filing for Q2 2018, filed 10 Aug 2018.